From light-activated pain relief to next-generation cancer immunotherapies, scientists and clinicians showcased bold ideas for translating lab discoveries into real-world treatments as part of the Accelerating BioVenture Innovation (ABI) program, part of Enterprise Innovation at Weill Cornell.